Homeostatic effect of laughter on diabetic cardiovascular complications: The myth turned to fact

dc.contributor.authorNoureldein, Mohamed H.
dc.contributor.authorEid, Assaad A.
dc.contributor.departmentAnatomy, Cell Biology, and Physiological Sciences
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:36:44Z
dc.date.available2025-01-24T11:36:44Z
dc.date.issued2018
dc.description.abstractAims Laughter has been used for centuries to alleviate pain in morbid conditions. It was not until 1976 that scientists thought about laughter as a form of therapy that can modulate hormonal and immunological parameters that affect the outcome of many serious diseases. Moreover, laughter therapy was shown to be beneficial in type 2 diabetes mellitus (T2DM) by delaying the onset of many diabetic complications. Laughter is also described to influence the cardiovascular and endothelial functions and thus may protect against diabetic cardiovascular complications. In this review, we outline the different biochemical, physiological and immunological mechanisms by which laughter may influence the overall state of wellbeing and enhance disease prognosis. We also focus on the biological link between laughter therapy and diabetic cardiovascular complications as well as the underlying mechanisms involved in T2DM. Methods Reviewing all the essential databases for “laughter” and “type 2 diabetes mellitus”. Results Although laughter therapy is still poorly investigated, recent studies show that laughter may retard the onset of diabetic complications, enhance cardiovascular functions and rectify homeostatic abnormalities associated with T2DM. Conclusions Laughter therapy is effective in delaying diabetic complications and should be used as an adjuvant therapy. © 2017 Elsevier B.V.
dc.identifier.doihttps://doi.org/10.1016/j.diabres.2017.11.014
dc.identifier.eid2-s2.0-85036593313
dc.identifier.pmid29162513
dc.identifier.urihttp://hdl.handle.net/10938/28702
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofDiabetes Research and Clinical Practice
dc.sourceScopus
dc.subjectCardiovascular diseases
dc.subjectDiabetes
dc.subjectDiabetic cardiomyopathy
dc.subjectDiabetic complications
dc.subjectLaughter
dc.subjectDiabetes complications
dc.subjectDiabetes mellitus, type 2
dc.subjectHomeostasis
dc.subjectHumans
dc.subjectChromogenin a
dc.subjectComplement component c3
dc.subjectEpinephrine
dc.subjectGlucose
dc.subjectGlycoprotein
dc.subjectGrowth hormone
dc.subjectHydrocortisone
dc.subjectImmunoglobulin a
dc.subjectImmunoglobulin e
dc.subjectImmunoglobulin g
dc.subjectImmunoglobulin g4
dc.subjectImmunoglobulin m
dc.subjectMessenger rna
dc.subjectProrenin
dc.subjectReactive oxygen metabolite
dc.subjectUnclassified drug
dc.subjectAdrenalin blood level
dc.subjectAlternative medicine
dc.subjectArterial pressure
dc.subjectArterial stiffness
dc.subjectCardiovascular disease
dc.subjectDiabetic complication
dc.subjectDiastolic blood pressure
dc.subjectGene expression regulation
dc.subjectGlucose blood level
dc.subjectHuman
dc.subjectHydrocortisone blood level
dc.subjectHypertension
dc.subjectHypothalamus hypophysis adrenal system
dc.subjectNatural killer cell
dc.subjectNon insulin dependent diabetes mellitus
dc.subjectNonhuman
dc.subjectPrognosis
dc.subjectPulse wave
dc.subjectQuality of life
dc.subjectReview
dc.subjectSaliva level
dc.subjectSystolic blood pressure
dc.subjectUpregulation
dc.subjectWellbeing
dc.subjectComplication
dc.subjectPathology
dc.subjectPhysiology
dc.titleHomeostatic effect of laughter on diabetic cardiovascular complications: The myth turned to fact
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-4416.pdf
Size:
914.88 KB
Format:
Adobe Portable Document Format